When was Phagenesis founded?

Phagenesis was founded in 2007 and raised its 1st funding round 3 years after it was founded.

Where is Phagenesis located?

Phagenesis is headquartered in Manchester, United Kingdom.

How many employees does Phagenesis have?

As of May 31, 2026, the latest employee count at Phagenesis is 78.

Is Phagenesis a funded company?

Phagenesis is a funded company, having raised a total of $62.1M across 4 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Sep 01, 2010.

When was the latest funding round of Phagenesis?

Phagenesis' latest funding was a $***** Series D round on Mar 04, 2024, with participation from 5 investors. Its primary sector is Neurology. In United Kingdom, the Neurology sector has seen $144M in funding in 2026 to date.

Where does Phagenesis rank among its competitors?

Phagenesis ranks 1st amongst 6 active competitors, of which 2 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Phagenesis, which secured $42M in Mar, 2024.

Who are the top competitors of Phagenesis?

Phagenesis' top competitors include Swallow Solutions, Viscgo and Ampcare. Among them, Phagenesis secured the most recent funding round in March, 2024.

Phagenesis - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Developer of medical devices for the treatment of Neurogenic dysphagia. The company has developed the Phagenyx System a neuromodulation system indicated to improve swallowing safety and efficiency to accelerate recovery from post-stroke dysphagia.

Website: phagenesis.com
Social

Key Metrics

Founded Year

2007

Location

Manchester, United Kingdom

Stage

Acquired

Total Funding

$62.1M in 4 rounds

Latest Funding Round

Series D, Mar 04, 2024, $*****

Investors

Sectoral & 11 more

Ranked

1^st among 6 active competitors

Employee Count

78 as on May 31, 2026

Similar Companies

Swallow Solutions & 6 more

Exit Details

Acquired by Nestle (Sep 01, 2016)

View Phagenesis' full profile

Phagenesis is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Phagenesis Limited CIN: 6308699 , Germany, Active	Jul 09, 2007	-	22 (As on Jan 31, 2022)

Phagenesis got acquired by Nestle on Sep 01, 2016.

Click here to take a look at Phagenesis's acquisition in detail

Phagenesis has raised a total funding of $62.1M over 4 rounds. Its first funding round was on Sep 01, 2010. Its latest funding round was a Series D round on Mar 04, 2024 for $*****. 5 investors participated in its latest round. Phagenesis has 12 institutional investors.

Here is the list of recent funding rounds of Phagenesis:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 04, 2024	4495498	Series D	3194907	7429260	5008419	8503158
May 22, 2013	2235561	Series B	7981371	5129295	9773364	Inventages
May 22, 2012	8965421	Grant (prize money)	4660695	9519952	2908754	Wellcome Trust

Access funding benchmarks and valuations. Sign up today!

View details of Phagenesis's funding rounds and investors

The founders of Phagenesis is Conor Mulrooney.

Here are the details of Phagenesis' key team members:

Conor Mulrooney: Co-Founder & COO of Phagenesis.
Contact Info: 1 email address

Phagenesis' Board of Directors

Phagenesis's board has 7 active members. Drew Burdon, Fredrik Malte Tobias Edenius, Michel Gardet, James Gibbons, Michael Sjostrom, Oern Stuge and Horace Hoskins are independent board members.

Here is the list of Phagenesis' board of directors:

Name	Type	Representing	Status	Duration
Drew Burdon	Independent board member	-	Current	2y 6m
iftkpab	Independent board member	-	Current	8y 1m
vnvmb{o	Independent board member	-	Current	5y 7m
qnhwdrn	Independent board member	-	Current	7y 4m
raysixd	Independent board member	-	Current	8y 1m
lfwgwpl	Independent board member	-	Current	2y 7m
k{bwa{e	Independent board member	-	Current	4y 3m

View details of Phagenesis's Founder profiles and Board Members

Phagenesis' employee count trend

Phagenesis has 78 employees as of May 26. Here is Phagenesis's employee count trend over the years:

Uncover Phagenesis' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Phagenesis include Swallow Solutions, Viscgo and Ampcare. Here is the list of Top 10 competitors of Phagenesis, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Phagenesis 2007, Manchester (United Kingdom), Acquired	Developer of medical devices for the treatment of Neurogenic dysphagia	$62.1M	Sectoral, EQT & 10 others	59/100
2nd	Swallow Solutions 2008, Madison (United States), Series A	Devices for diagnosing and treating dysphagia through oropharyngeal strengthening	$3.23M	Venture Management, NEW Capital Fund & 4 others	35/100
3rd	Viscgo 2015, United Kingdom, Seed	Manufacturer of dysphagia management devices	$797K	Deepbridge Capital, Catapult Ventures & 1 others	26/100
4th	Ampcare 2007, Fort Worth (United States), Unfunded	Dysphagia therapy solutions using neuromuscular electrical stimulation and specialized protocols	-	-	26/100
5th	Eswallow USA 2009, Scottsboro (United States), Unfunded	Neuromuscular stimulation devices for the treatment of dysphagia	-	-	24/100
6th	Ampcare 2007, Fort Worth (United States), Unfunded	Develops device for the treatment of dysphagia	-	-	24/100
7th	Innovative Neurotronics 2004, Nevada (United States), Deadpooled	Therapeutic neuro-rehabilitation devices	-	-	20/100
8th	Rymo Medical 2015, Costa Mesa (United States), Deadpooled	Domain marketplace offering secure transactions and buyer protection	-	-	15/100